(PubMed) Klein EA, Thompson IM, Jr., Tangen CM, et al
PT-141 is not contraindicated with nitrates the way PDE5 inhibitors are, but it still requires clinician oversight
Some new data came in on June 8: Lilly reported Foundayo beat oral semaglutide head-to-head in type 2 diabetes (ACHIEVE-3): 9.2% weight loss and 2.2% A1C reduction at 17.2 mg vs 5.3% / 1.4% for oral sema
Understanding what GLP-1 drugs are, how they are delivered, and what is known about patch products can help patients make safer, more informed decisions
Rheumatology 60 , 28162825 (2021)
Due to their high metabolic demand, cancer cells exhibit fluctuating yet elevated ROS levels compared to non-transformed cells [5]